Medical School News and Research

RSS

Emergency departments could help boost annual flu vaccination rates

A University of California, Riverside-led study of more than 3,200 emergency department (ED) patients across the United States found that while awareness of influenza vaccination is widespread, most adults seen in EDs are not up to date on their annual flu vaccine.

17 Jun 2026

Deep learning identifies novel compounds against antibiotic-resistant gonorrhea

With tens of millions of annual cases, gonorrhea is the second most frequently reported sexually transmitted infection (STI). Alone in the U.S., over 600,000 cases are reported each year.

17 Jun 2026

U-M Health neurosurgeons complete first human implant of wireless brain computer interface

Neurosurgeons at University of Michigan Health completed the first-in-human implant of a Paradromics Inc., wireless brain-computer interface, or BCI, as part of a national clinical trial for patients with difficulty speaking.

17 Jun 2026

Age-related muscle loss linked to increased tumor growth

Duke-NUS scientists have discovered that aging muscle may contribute to cancer growth by releasing fewer extracellular vesicles, tiny particles that cells use to communicate with one another.

16 Jun 2026

Losing smell and taste may profoundly affect wellbeing

University of East Anglia research reveals that smell loss can affect quality of life as severely as conditions including diabetes, stroke, Parkinson's, and kidney failure.

16 Jun 2026

New grant supports research into blinding retinal diseases

A University of Minnesota Medical School research team has been awarded a 4-year, $2.2 million grant from the National Eye Institute to better understand the underlying causes of retinal diseases, such as age-related macular degeneration (AMD), and develop new treatments that could benefit patients.

16 Jun 2026

Semaglutide, omega-3s and diet shift epigenetic aging clocks in human studies

A systematic review identified 41 human studies evaluating interventions targeting next-generation DNA methylation-based aging clocks. Pharmaceutical, lifestyle, supplement, clinical, and psychosocial interventions shifted some clock outputs, but these biomarkers remain investigational rather than proven clinical surrogates.

16 Jun 2026

Study identifies top predictors for weight loss using tirzepatide

One of the largest real-world studies of people taking GLP-1 medications found women, those without pre-existing conditions such as type 2 diabetes and high blood pressure, and behavioral factors such as previously setting a weight goal were the best predictors of total weight loss, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

16 Jun 2026

Researchers urge caution over large-scale newborn genome screening

New research from large population studies provides invaluable evidence on genome screening of newborn babies to reduce risks from overdiagnosis.

15 Jun 2026

GLP-1s may improve testosterone levels and sperm quality in men with obesity

GLP‑1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2026

Engineered blood clots form faster to stop severe bleeding

Blood clotting is one of the body's oldest survival mechanisms-a biological defense that has protected humans from dangerous bleeding for millions of years.

15 Jun 2026

Dual-target CAR T therapy triggers broad immune response in brain cancer

Dual-target CAR T cell therapy for recurrent glioblastoma (GBM), delivered directly into the cerebrospinal fluid (CSF), triggers a broad immune response, with natural killer (NK) cell activation linked to better patient outcomes and longer overall survival.

15 Jun 2026

Targeted reminders increase serious illness conversations in cancer care

New research in the June 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that small, targeted prompts delivered to both patients and providers at the right moment can significantly increase the number of serious illness conversations that take place.

15 Jun 2026

New guideline recommends tailored care for precocious puberty

Some subgroups of children with precocious puberty-such as older girls with slowly progressing puberty-may not need the same level of testing or treatment, according to a new Endocrine Society Clinical Practice Guideline released today.

14 Jun 2026

FDA approves new adjuvant treatment option for ccRCC patients with recurrence risk

The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component (ccRCC) at intermediate-high or high risk of recurrence following nephrectomy, with or without resection of metastatic lesions.

12 Jun 2026

Study identifies immune pathway driving long-term concussion damage

Traumatic brain injuries (TBI) - even mild concussions - may trigger a chain reaction in the brain that disrupts neuronal communication, long-term memory, and cognition, according to University of California, Riverside research investigating how the brain's immune system responds after injury.

12 Jun 2026

Study links migrant status to slower NHS career progression

Ethnic minority healthcare workers who are also born overseas face a double disadvantage due to the combined effects of ethnicity and migrant status, according to new research published in JRSM Open.

12 Jun 2026

Childhood lead exposure declines but disparities persist nationwide

Blood lead levels in young children in the United States declined in the last decade, but state data reveal that children of color and children from low-wealth families are still exposed to higher levels of lead, according to a new study in the American Journal of Public Health.

11 Jun 2026

Metformin reduces long COVID risk according to ACTIV-6 clinical trial

New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.

11 Jun 2026

Multiple screening methods protect integrity of online health research

While online research is a useful way to reach people who may not take part in in-person studies, researchers are increasingly concerned that fake, automated, and duplicate survey responses can reduce data quality and compromise findings.

11 Jun 2026